Clinical trials
Terminated Phase 1 Renal Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| AstraZeneca | 3 |
| Mayo Clinic | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Acrotech Biopharma Inc. | 1 |
| Anthera Pharmaceuticals | 1 |
| Boehringer Ingelheim | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Gilead Sciences | 1 |
| H. Lundbeck A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 28 |
| Kidney Diseases | 4 |
| Kidney Failure, Chronic | 4 |
| Heart Failure | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Renal Insufficiency, Chronic | 2 |
| Anemia, Sickle Cell | 1 |
| COVID-19 | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetic Nephropathies | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.